AzTrials
AzTrials

Mild Cognitive ImpairmentNCT03528486

Interventions to Attenuate Cognitive Decline: Keys to Staying Sharp

A study testing Music Training I in people with Mild Cognitive Impairment and Age-related Cognitive Decline, run by University of South Florida at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Different cognitive intervention approaches have been developed to attenuate decline (e.g., cognitive engagement, training, or stimulation), but it is not clear which approaches are efficacious. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
What is being tested?
Music Training I
Could I receive a placebo?
No, everyone receives an active treatment
How many people
268 participants
Where
1 siteUnited States
Study dates
29 Jan 2018to 30 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • aged 60 years or older
  • willingness to provide informed consent
  • willingness to complete up to 23 study visits including attending in-lab intervention two times a week for a three-month period with the goal of completing 20 sessions.
  • ability to speak and understand English
  • Montreal Cognitive Assessment score of 20 or higher (score 20 to 30 inclusive)
  • intact vision (binocular near visual acuity of 20/50 or better tested with a standard near visual acuity chart)
Show all 9Show fewer
  • adequate hearing acuity (no greater than a moderate hearing loss [thresholds <70 dB HL] in the mid-frequency range [1000, 2000 Hz] in at least one ear as determined by a standard pure tone hearing evaluation)
  • Music Reading Assessment score of 18 or lower (score 0-18 inclusive)
  • ability to understand study procedures and comply with them for the length of the study in the tester's opinion (and other study personnel opinion who interact with participant, such as the study physician)

Who cannot join

  • moderate or worse depressive symptoms (Geriatric Depression Scale short form score >=5)
  • previous participation in University of South Florida (USF) Cognitive Aging Lab intervention studies
  • previous participation in 10 or more hours of a computerized cognitive intervention computer programs (e.g., Lumosity, Posit Science Brain Fitness, InSight, or BrainHQ; Lace, CogMed, CogniFit, Happy Neuron, Dakim, DriveSharp or Staying Sharp programs)
  • currently enrolled in another research study
  • planning on being away for two or more weeks during the next five months (recruit later)
  • undergoing chemotherapy or radiation treatment or planning surgeries or other procedures requiring anesthesia within the next five months (recruit later)
Show all 16Show fewer
  • four or more years of formal music training such as private lessons or group lessons on a specific instrument
  • ability to read music on two or more of the following clefs: Treble clef, Bass clef, Alto clef
  • four or more years of playing any one musical instrument
  • currently practicing or participating in any music activities- such as music performance or music reading or music lessons
  • difficulty and pain in moving hands or fingers, or neuropathy affecting hands, or tremor in either hand
  • self-reported diagnosis of dementia, stroke, serious brain injury or neurological disorder
  • diagnosed by a physician or nurse with a TIA that occurred within the last 18 months
  • inability or unwillingness to give written informed consent at baseline
  • Clinical Dementia Rating Scale score of 1 or greater
  • Clinical diagnosis of dementia or other disorder that in the study physician's opinion would limit the persons ability to participate in the study or benefit from the interventions

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of South Florida

    Tampa, Florida, 33620

Other trials in United States

About this study

Official title: Interventions to Attenuate Cognitive Decline

Different cognitive intervention approaches have been developed to attenuate decline (e.g., cognitive engagement, training, or stimulation), but it is not clear which approaches are efficacious. It is also not clear when, along the continuum of normal cognitive aging to mild cognitive impairment (MCI-a transitional stage before dementia onset), it is most efficacious to intervene. This randomized clinical trial will determine the efficacy of a novel cognitive engagement intervention approach (music training) as compared to cognitive stimulation (which will serve as a stringent, active control). Grounded in theory, the central hypothesis is that interventions enhancing central auditory processing (CAP), a strong, longitudinal predictor of MCI and dementia, will improve cognition. Music training is increasingly recognized as a feasible means to attenuate age-related cognitive decline. Prior research and preliminary data suggest that intense piano training enhances CAP and is likely more effective than cognitive stimulation. Correlational studies indicate superior CAP, executive function, and other cognitive abilities for adults with formal music training compared to non-musicians. The specific aims of the study are to examine the efficacy of music training relative to cognitive stimulation (active controls) to improve CAP, cognition, and everyday function among older adults with and without MCI. The efficacy of music training will be established and moderating effects of MCI status will be examined. The proposed study further aims to elucidate the underlying mechanisms of effective cognitive intervention approaches by exploring mediators of training gains. The proposed study is the first phase II randomized trial of music training to enhance older adults' cognition. Mediation analyses will elucidate the underlying mechanisms of intervention effects.

Read the detailed description

Interventions to Attenuate Cognitive Decline: Keys to Staying Sharp.

The primary objectives is to examine the efficacy of music training to improve central auditory processing (CAP), cognition, and everyday function among older adults.

The secondary objectives are:

  • To examine the moderating effects of mild cognitive impairment (MCI) on music training efficacy.
  • To explore mediators of intervention effects.

Design The design is a two arm randomized clinical trial examining the efficacy of music training to improve CAP, cognition, and everyday function in older adults with and without MCI across two time points (baseline and immediate post-test).

Outcomes The effects of of music training on CAP, cognition, and everyday functional performance will be quantified.

CAP processing measures will include: Time Compressed Speech 65%, Words-in-Noise, Dichotic Digits Test, Dichotic Sentence Identification, and Adaptive Tests of Temporal Resolution. A composite will be derived from principal components analyses.

Cognition measures will include: Verbal Fluency Test (phonemic fluency, category fluency, and category switching), Trail Making Test, and Digit Coding. A composite will be derived from principal component analyses.

Everyday Function measures will include: Timed Instrumental Activities of Daily Living and Test of Everyday Attention. A composite will be derived from principal component analyses.

Interventions and Duration Two types of music training will be investigated. The two training conditions will be equivalent in terms of frequency and duration of each session (90 min/day, two days/wk, 10 weeks) and social contact (led by trainer and conducted in groups of up to 10 persons).

Sample Size and Population In-person screening of a maximum of 500 potential study participants are planned to enroll up to 400 participants. The goal is to have at least 200 participants complete the study. Individuals with normal cognition and those with a clinical diagnosis of MCI will be included in the study.

Being tested
Music Training I
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Music Training IBehavioural

    Participants will be attending group classes, guided by a trainer, with up to 10 other older adults.

Study groups in NCT03528486
Study groupRoleWhat they receive
Music Training IExperimentalParticipants will complete a type of music training including listening to music, learning about music, or learning to read music, or play a musical instrument.
Receives: Behavioral: Music Training I
Music Training IIActive comparatorParticipants will complete a type of music training including listening to music, learning about music, or learning to read music, or play a musical instrument
Receives: Behavioral: Music Training I

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognition

    A composite of performance on Verbal fluency words generated, Trail Making Test time, and Digit Symbol Coding number correct derived from principal components analyses

    Measured: change from baseline to immediate post intervention at the end of study completion which is a period of about 6 months

Secondary outcomes (2)
  1. Central Auditory Processing

    A composite will be formed from principal components analyses of number correct for performance on Time Compressed Speech Test (TCS), Words-in-Noise Test (WIN), Dichotic Digits Test (DDT), Dichotic Sentence Identification (DSI) and the threshold in ms of performance on the Adaptive Tests of Temporal Resolution (ATTR).

    Measured: change from baseline to immediate post intervention at the end of study completion which is a period of about 6 months

  2. Everyday Function

    A composite will be formed from the time and accuracy of performance on the Timed IADL Test and The Test of Everyday Attention (TEA)

    Measured: change from baseline to immediate post intervention at the end of study completion which is a period of about 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2018
  2. Study start29 Jan 2018
  3. Primary completion30 Aug 2021
  4. Study completion30 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
268 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03528486
Sponsor's protocol ID
32335
Status last verified
May 2024
First submitted
13 Mar 2018
Last updated
21 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Runge SK, Hudak EM, Sutfin JA, Dobrovolskiy VR, Edwards JD. The influence of peer navigators on intervention adherence and retention among older adults: A study within a randomized trial - SWAT. Contemp Clin Trials. 2026 Feb;161:108206. doi: 10.1016/j.cct.2025.108206. Epub 2025 Dec 24.

    PubMed 41453521
  • Hudak EM, Bugos J, Andel R, Lister JJ, Ji M, Edwards JD. Keys to staying sharp: A randomized clinical trial of piano training among older adults with and without mild cognitive impairment. Contemp Clin Trials. 2019 Sep;84:105789. doi: 10.1016/j.cct.2019.06.003. Epub 2019 Jun 18.

    PubMed 31226405

Questions about this trial

What is this clinical trial studying?

A study testing Music Training I in people with Mild Cognitive Impairment and Age-related Cognitive Decline, run by University of South Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognition (time frame: change from baseline to immediate post intervention at the end of study completion which is a period of about 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03528486, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in